Radiopharmaceuticals
| 9: 111In-INDIUM LABELLING
OF WHITE BLOOD CELLS (with 111In-tropolonate in
plasma) (MRC Cyclotron Unit, Hammersmith Hospital) |
||
| Method | ||
| 1. | Dispense 9 ml of ACD (Formula A) into each of two 60 ml syringes | |
| 2. | Withdraw 51 ml of the patient's blood into each syringe using a 19 G (non-intermittent) butterfly | |
| 3. | Dispense 2 ml of 6% w/v hydroxyethyl starch into 5 internally sterile 20 ml tubes | |
| 4. | Dispense 20 ml of anticoagulated blood into each of the internally sterile 20 ml tubes containing the sedimentation agent, mix by one gentle inversion and leave for 45-60 min to sediment the red cells | |
| 5. | Dispense the remaining 20 ml of blood into an internally sterile 20 ml tube not containing sedimentation agent and centrifuge at 1500 g for 10 min. The supernatant contains cell-free plasma and ACD which is used as the cell labelling medium and for suspending the radiolabelled cells for re-injection | |
| 6. | After the red cells have sedimented (step 4), remove the leucocyte-rich platelet-rich plasma (LRPRP) into internally sterile 20 ml tubes | |
| 7. | Centrifuge the LRPRP at 150 g for 5 min to give a pellet of leucocytes and a supernatant containing platelet-rich plasma (PRP) | |
| 8. | Transfer PRP to an internally sterile 20 ml tube and centrifuge at 1500 g for 10 min to obtain cell-free plasma. This used for washing the cells after labelling | |
| 9. | Resuspend the leucocytes in 1 ml of cell-free plasma from step 5 | |
| 10. | Add 0.1 ml of tropolone solution (0.054% w/v in HEPES-saline buffer, pH 7.6), followed by 30 MBq of 111In-indium chloride solution to the cells | |
| 11. | Incubate the cells for 5-10 min at room temperature | |
| 12. | Add 5-10 ml of cell-free plasma from step 8 and centrifuge at 150 g for 5 min | |
| 13. | Remove the supernatant and retain for determining the labelling efficiency | |
| 14. | Resuspend the cells in 3-4 ml of cell-free plasma from step 5. Check the activity (20 MBq is the diagnostic reference level) and calculate the labelling efficiency | |
|
-------------------------------------- |
||
Back to Formulary Section
Back to Radiopharmacy Handbook Index